Sol-Gel Technologies Common Stock

The latest common stock for SLGL is $1.3M as of March 2026. That compares with $770K in the prior-year period — up 70.7% year over year. Investors often review this figure alongside Sol-Gel Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, SLGL's common stock moved from $770K to $1.3M — a 70.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sol-Gel Technologies's operating scale or balance-sheet position.

A common stock figure of $1.3M for SLGL is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SLGL's common stock ($1.3M), review year-over-year change from $770K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Sol-Gel Technologies's common stock against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.